Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2025 13:58 ET | Source: Spherix Global Insights

Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

EXTON, PA, April 10, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists...
June 13, 2024 10:16 ET | Source: Spherix Global Insights

Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics

EXTON, PA, June 13, 2024 (GLOBE NEWSWIRE) -- Since 2021, the treatment options for systemic lupus erythematosus (SLE) and lupus nephritis (LN) have expanded with the approval of AstraZeneca’s...
March 25, 2024 19:43 ET | Source: Research and Markets

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
October 27, 2021 20:00 ET | Source: DelveInsight Business Research LLP

DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere

Las Vegas, USA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere The...
August 22, 2019 09:00 ET | Source: Zylö Therapeutics

Zylö and Hoth Therapeutics Forge Partnership to Develop Endocannabinoid-Based Drug to Treat Lupus

Zylö’s xerogel-derived delivery platform to be used to topically deliver the drug candidate Greenville, SC, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to bringing innovative...
November 01, 2018 09:45 ET | Source: Zylö Therapeutics

Endocannabinoids Demonstrate Efficacy in Lupus Model

Zylö’s Nanopod™ Delivery Technology Plays Key Role GREENVILLE, SC, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zylö Therapeutics, a life science innovator bringing affordable first-to-market therapies to...